2 results
Approved WMOWill not start
To compare the progression-free survival (PFS) in subjects with pancreatic islet cell tumors treated with sunitinib at a starting dose of 37.5 mg daily (continuous dosing) with those treated with placebo.
Approved WMORecruiting
In this study, we look at how safe the new medicinal product rusfertide is for the treatment of Polycythemia vera. And how well it works.